Moxifloxacin-d4 CAS CATO-CCAD303853
| CAS No. | CATO-CCAD303853 |
| Molecular Formula | - |
| Molecular Weight | 405.46 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
Moxifloxacin-d4 (CAS CATO-CCAD303853), molecular formula C21H20D4FN3O4 and molecular weight 405.46 g/mol, is a CATO reference standard with documented purity and traceability.
Owing to deuterium isotope labeling, a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution, Moxifloxacin-d4 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 405.46 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
CATO manufactures Moxifloxacin-d4 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C21H20D4FN3O4 |
| Molecular Weight | 405.46 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Moxifloxacin Standards
- Moxifloxacin impurity 169 (CAS CATO-C4X-1074169)
- MOXIFLOXACIN (CAS 1346747-14-5)
- Moxifloxacin (CAS 354812-41-2)
- Moxifloxacin Impurity 40(S,R) (CAS 855661-74-4)
- Moxifloxacin Impurity 41(R,S) (CAS 855661-71-1)
- Moxifloxacin EP Impurity D (CAS 1029364-77-9)
- Moxifloxacin EP Impurity G (CAS 268545-13-7)
- Moxifloxacin (CAS 151096-09-2)
Recommended Standards
- Ezetimibe Impurity 33 (CAS 1700622-07-6)
- N-(2-methoxybenzyl)-2-(4-oxo-7-phenylthieno[3,2-d]pyrimidin-3(4H)-yl)acetamide (CAS 1105206-73-2)
- Paroxetine HCl Anhydrous EP Impurity J (CAS CATO-C4X-103534)
- N-(2-ethoxyphenyl)-2-(4-oxo-7-phenylthieno[3,2-d]pyrimidin-3(4H)-yl)acetamide (CAS 1105224-16-5)
- Methyl 6-(benzyloxy)-2-fluoro-3-methylbenzoate (CAS 2484888-74-4)
- {3-[3-(3-fluorophenyl)-1H-pyrazol-5-yl]propyl}(methyl)amine (CAS 1232136-36-5)
- 1-(4-Iodophenyl)adamantane (CAS 98611-00-8)
- Ethyl 4-ethylnicotinate (CAS 389570-73-4)
- 2-Ethoxy-4-methylaniline (CAS 23385-44-6)
- 1-(3-Bromopropoxy)-2-methylbenzene (CAS 50912-60-2)
- 2-((5-Bromo-1H-indol-3-yl)thio)acetic acid (CAS 2324170-26-3)
- 4,6-Dichloro-N,N-diethyl-1,3,5-triazin-2-amine (CAS 1722-19-6)
- 2-Amino-4-(6-nitrobenzo[d][1,3]dioxol-5-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (CAS 315245-17-1)
- Des-Ile27-Tirzepatide (CAS CATO-CPTD788946)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com